Provided by Tiger Trade Technology Pte. Ltd.

Biofrontera Inc

1.19
-0.1700-12.50%
Post-market: 1.250.0599+5.03%19:32 EDT
Volume:1.48M
Turnover:1.87M
Market Cap:17.67M
PE:-2.19
High:1.36
Open:1.33
Low:1.17
Close:1.36
52wk High:1.66
52wk Low:0.5547
Shares:14.85M
Float Shares:10.55M
Volume Ratio:1.08
T/O Rate:14.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5426
EPS(LYR):-1.0358
ROE:-988.35%
ROA:-17.45%
PB:2.97
PE(LYR):-1.15

Loading ...

Biofrontera Gains FDA Approval for Ameluz Skin Cancer Use

TIPRANKS
·
Sep 14

Biofrontera announces FDA approval of Ameluz supplemental new drug application

TIPRANKS
·
Sep 14

Biofrontera Announces FDA Approval of Ameluz® Red Light Pdt for the Treatment of Superficial Basal Cell Carcinoma

THOMSON REUTERS
·
Sep 14

Biofrontera - to Launch Sbcc Indication Late Q4 2026 Through Q1 2027

THOMSON REUTERS
·
Sep 14

Biofrontera Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Biofrontera Q2 Revenue Rises on Higher Volume, Pricing

Reuters
·
Aug 13

Biofrontera Q2 EPS $(0.05) Misses $(0.04) Estimate, Sales $12.003M Beat $10.500M Estimate

Benzinga Earnings
·
Aug 13

Biofrontera Q2 Revenue USD 12 Million

Reuters
·
Aug 13

Biofrontera Q2 Adjusted Ebitda USD -200 Thousand

THOMSON REUTERS
·
Aug 13

Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth

GlobeNewswire
·
Aug 13

Biofrontera Inc Expected to Post a Loss of 10 Cents a Share - Earnings Preview

Reuters
·
Aug 11

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026

GlobeNewswire
·
Aug 06

Biofrontera Plans Move from Prime Standard to Frankfurt’s Scale Segment

TIPRANKS
·
Jul 28

Biofrontera’s Acne PDT Trial Completion: What Investors Should Watch Next

TIPRANKS
·
Jul 09

Biofrontera’s Phase III Actinic Keratosis Study Nears Data Payoff for Investors

TIPRANKS
·
Jul 08

Biofrontera Shareholders Approve Director Elections and Equity Plan

TIPRANKS
·
Jun 18

Biofrontera shareholders approve amended 2021 omnibus incentive plan share increase to 8,750,000

Reuters
·
Jun 18

Biofrontera Earnings Call Highlights Growth And Risks

TIPRANKS
·
Jun 03

Biofrontera FY26 Q1 pretax profit more than doubles to EUR 2.2 million

Reuters
·
May 30

Biofrontera participates in Lytham Partners Spring 2026 Investor Conference webcast

Reuters
·
May 21